Core Scientific (CORZ) EBT Margin (2021 - 2026)

Core Scientific (CORZ) has 6 years of EBT Margin data on file, last reported at 300.74% in Q1 2026.

• For the quarter ending Q1 2026, EBT Margin fell 102562.0% year-over-year to 300.74%; the trailing twelve-month figure through Mar 2026 stood at 341.4% (down 8065.0% YoY), and the FY2025 full-year result was 90.29%, up 19111.0% from the prior year.
• EBT Margin eased to 300.74% in Q1 2026, from 270.87% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 724.87% in Q1 2025 to a low of 1191.23% in Q2 2025.
• A 5-year average of 208.33% and a median of 220.13% in 2022 frame the typical range for EBT Margin.
• Across the five-year window, EBT Margin jumped 60725 bps in 2025 and tumbled 102562 bps in 2026, its largest moves.
• Tracing CORZ's EBT Margin over 5 years: stood at 376.36% in 2022, then surged by 63 bps to 137.64% in 2023, then tumbled by 123 bps to 306.32% in 2024, then jumped by 188 bps to 270.87% in 2025, then plunged by 211 bps to 300.74% in 2026.
• Business Quant data shows CORZ's EBT Margin at 300.74% in Q1 2026, 270.87% in Q4 2025, and 177.43% in Q3 2025.